2) “It’s one thing not to have benefit, but this shows distinct harm,” said Eric Topol, a cardiologist and director of the Scripps Research Translational Institute. “If there was ever was hope for this drug, this is the death of it.” 
-
-
Show this thread
-
3) Patients studied from existing patient registries (important because it was pre recorded). Patients all strictly given HCQ or CQ within 48 hours of
#covid19 diagnosis after hospitalization. Excluded if delayed.pic.twitter.com/ce722eMZYa
Show this thread -
4) “The treatment groups included 1868 patients who were given chloroquine alone, 3016 given hydroxychloro- quine alone, 3783 given chloroquine w/ macrolide and 6221 given hydroxychloroquine and macrolide. The median time from hospitalisation to diagnosis of COVID-19 was 2 days.
Show this thread -
5) “The mean daily dose and duration: chloroquine alone, 765 mg (SD 308) and 6·6 days (2·4); hydroxychloroquine alone, 596 mg (126) and 4·2 days (1·9); chloroquine w/ macrolide, 790 mg (320) and 6·8 days (2·5); and hydroxychloroquine w/ macrolide, 597 mg (128) and 4·3 days (2·0)”
Show this thread -
6) “No significant between-group differences were found among baseline characteristics or comorbidities.”
THIS IS QUITE REMARKABLE. Balanced means no baseline confounding. Akin to what you might see in a trial usually, except it wasn’t. Very reassuring.pic.twitter.com/ITMJcnzQ1z
Show this thread -
7) “Analyses using propensity score matching by treatment group... indicated that associations between drug regimens and mortality, need for mechanical ventilation, length of stay, and the occurrence of de-novo ventricular arrhythmias were consistent with the primary analysis.”
Show this thread -
8) “David Maron, director of preventive cardiology at the Stanford University School of Medicine, said that “these findings provide absolutely no reason for optimism that these drugs might be useful in the prevention or treatment of covid-19.”
Show this thread -
9) Nearly 15,000 of the 96,000 patients in the analysis were treated with hydroxychloroquine or chloroquine alone or in combination with a type of antibiotics known as a macrolide, such as azithromycin, within 48 hours of their diagnosis.
Show this thread -
10) The mean age was 54 years, and 53 percent were men. Those who were on mechanical ventilators or who received remdesivir, an antiviral drug made by Gilead Sciences that has shown promise in decreasing recovery times, were excluded.
Show this thread -
11) For those given hydroxychloroquine, there was 34% increase in risk of mortality & 137% increased risk of serious heart arrhythmias. For those receiving hydroxychloroquine +antibiotic — there was 45% increased risk of death & 411% increased risk of serious heart arrhythmias.
Show this thread -
12) “Those given chloroquine had a 37% increased risk of death and a 256% increased risk of serious heart arrhythmias. For those taking chloroquine and an antibiotic, there was a 37% increased risk of death and a 301% increased risk of serious heart arrhythmias.”
Show this thread -
13) Clarification of “increased risk” nomenclature: hazard ratio of 5.0 denotes “inc risk by 5x” (drug user risk = 5*non user risk), or can also be described as a “400% increased risk of outcome”. In 1st post, I used the 5x language, which is same as 400% inc risk of X language.
Show this thread -
14) Amazing that data came together from 671 hospitals across 6 continents!pic.twitter.com/znerDGeFgA
Show this thread -
15) In appendix, they also present results of a COMPOSITE endpoint if either mechanical ventilation or death (whichever came first in the Cox PH analysis). Results mostly same as the mortality endpoint, and even moderately stronger than death alone.pic.twitter.com/59P42Ncp82
Show this thread -
16) Other risk factors that stand out for higher risk of death:
Men
Adiposity (BMI)
Blacks and Hispanics vs White
Heart disease
Diabetes
Hypertension
High cholesterol
Smoking

Non-users of ACE inhibitor*

Non-users of statins*
*Neat but need confirmation.pic.twitter.com/XMUIglGTwt
Show this thread -
17) the strong findings of lower risk death for ACE inhibitors and statin users is interesting. But they area already drugs that are well known to lower risk of death. But do they lower even more among COVID patients? Unclear.
Show this thread -
18) And racial data, I don’t want to overinterpret yet, because I don’t know if Blacks in Africa should be compared to whites in US/Europe. Prefer data on African Americans vs Whites in NA & African Europeans vs Whites in Europe w/in any continent. Same for Asians and Hispanics.
Show this thread -
19) BOTTOMLINE: this study demonstrating CQ & HCQ increasing risk of death is an epic body of work representing amazing collaboration of 671 hospitals. Though not trial, it’s hospital registry data that is quite strong longitudinal design.
Do NOT take HCQ or CQ at this time!Show this thread
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.
